Exploiting induced pluripotent stem cell-derived macrophages to unravel host factors influencing Chlamydia trachomatis pathogenesis

Chlamydia trachomatis remains a leading cause of bacterial sexually transmitted infections and preventable blindness worldwide. There are, however, limited in vitro models to study the role of host genetics in the response of macrophages to this obligate human pathogen. Here, we describe an approach using macrophages derived from human induced pluripotent stem cells (iPSdMs) to study macrophage–Chlamydia interactions in vitro. We show that iPSdMs support the full infectious life cycle of C. trachomatis in a manner that mimics the infection of human blood-derived macrophages. Transcriptomic and proteomic profiling of the macrophage response to chlamydial infection highlighted the role of the type I interferon and interleukin 10-mediated responses. Using CRISPR/Cas9 technology, we generated biallelic knockout mutations in host genes encoding IRF5 and IL-10RA in iPSCs, and confirmed their roles in limiting chlamydial infection in macrophages. This model can potentially be extended to other pathogens and tissue systems to advance our understanding of host-pathogen interactions and the role of human genetics in influencing the outcome of infections.

[1]  Jun S. Liu,et al.  Genetics of rheumatoid arthritis contributes to biology and drug discovery , 2013 .

[2]  J. Rowley,et al.  Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP‐1 with an MLL‐AF9 translocation , 2000, Genes, chromosomes & cancer.

[3]  U. Andersson,et al.  IFN-αβ-Dependent, IFN-γ Secretion by Bone Marrow-Derived Macrophages Controls an Intracellular Bacterial Infection , 2001, The Journal of Immunology.

[4]  S. Schmidt,et al.  New Insights into IDO Biology in Bacterial and Viral Infections , 2014, Front. Immunol..

[5]  H. Gérard,et al.  Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. , 1998, The Journal of rheumatology.

[6]  K. A. Fields,et al.  Perforin-2 Restricts Growth of Chlamydia trachomatis in Macrophages , 2013, Infection and Immunity.

[7]  W. Skarnes,et al.  Bi-allelic gene targeting in mouse embryonic stem cells. , 2011, Methods.

[8]  U. Farooq,et al.  Simultaneous Transcriptional Profiling of Bacteria and Their Host Cells , 2013, PloS one.

[9]  S. Fortune,et al.  NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis , 2009, PLoS pathogens.

[10]  G. Dougan,et al.  Induced Pluripotent Stem Cell Derived Macrophages as a Cellular System to Study Salmonella and Other Pathogens , 2015, PloS one.

[11]  M. Lehmann,et al.  Expression of interferon regulatory factors and indoleamine 2,3-dioxygenase in Chlamydia trachomatis-infected synovial fibroblasts , 1999, Medical Microbiology and Immunology.

[12]  S. Hanash,et al.  Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral Infection* , 2004, Journal of Biological Chemistry.

[13]  W. Skarnes,et al.  Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cells , 2017, Development.

[14]  Nahum Sonenberg,et al.  Host Translation at the Nexus of Infection and Immunity , 2012, Cell Host & Microbe.

[15]  U. Andersson,et al.  IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. , 2001, Journal of immunology.

[16]  D. Virok,et al.  Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression. , 2003, The Journal of infectious diseases.

[17]  G. Byrne,et al.  Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism. , 2013, Future microbiology.

[18]  P. Timms,et al.  Chlamydia trachomatis infection: host immune responses and potential vaccines , 2008, Mucosal Immunology.

[19]  H. Zeidler,et al.  Persistent infection of Chlamydia in reactive arthritis , 2006, Annals of the rheumatic diseases.

[20]  C. Black,et al.  The intercellular adhesion molecule type‐1 is required for rapid activation of T helper type 1 lymphocytes that control early acute phase of genital chlamydial infection in mice , 1999, Immunology.

[21]  Jianguo Xia,et al.  NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data , 2015, Nature Protocols.

[22]  M. Arababadi,et al.  Significant Roles Played by IL-10 in Chlamydia Infections , 2014, Inflammation.

[23]  J. York,et al.  Chlamydia trachomatis evokes a relative anti-inflammatory response in a free Ca2+ dependent manner in human macrophages. , 2010, Comparative immunology, microbiology and infectious diseases.

[24]  I. Udalova,et al.  IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo , 2013, Mediators of inflammation.

[25]  T. Darville,et al.  Chlamydia trachomatis Induces Expression of IFN-γ-Inducible Protein 10 and IFN-β Independent of TLR2 and TLR4, but Largely Dependent on MyD881 , 2005, The Journal of Immunology.

[26]  B. Menten,et al.  In vitro human embryonic stem cell hematopoiesis mimics MYB independent yolk sac hematopoiesis , 2014 .

[27]  A. Basnakian,et al.  Interferon Regulatory Transcription Factor 3 Protects Mice from Uterine Horn Pathology during Chlamydia muridarum Genital Infection , 2011, Infection and Immunity.

[28]  H. Caldwell,et al.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis , 1981, Infection and immunity.

[29]  D. Margolis,et al.  Chlamydiapneumoniae Inhibits Apoptosis in Human Peripheral Blood Mononuclear Cells Through Induction of IL-101 , 2000, The Journal of Immunology.

[30]  K. Honda,et al.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors , 2006, Nature Reviews Immunology.

[31]  R. Skilton,et al.  Genetic Transformation of a Clinical (Genital Tract), Plasmid-Free Isolate of Chlamydia trachomatis: Engineering the Plasmid as a Cloning Vector , 2013, PloS one.

[32]  A. Hudson,et al.  Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. , 1995, Arthritis and rheumatism.

[33]  T. Rudel,et al.  Apoptosis resistance in Chlamydia-infected cells: a fate worse than death? , 2009, FEMS immunology and medical microbiology.

[34]  R. Harrison,et al.  Chlamydia trachomatis vacuole maturation in infected macrophages , 2012, Journal of leukocyte biology.

[35]  Helen E. Parkinson,et al.  The human-induced pluripotent stem cell initiative—data resources for cellular genetics , 2016, Nucleic Acids Res..

[36]  Ami A. Shah,et al.  IRF5 polymorphism predicts prognosis in patients with systemic sclerosis , 2012, Annals of the rheumatic diseases.

[37]  T. Darville,et al.  Chlamydia trachomatis induces expression of IFN-gamma-inducible protein 10 and IFN-beta independent of TLR2 and TLR4, but largely dependent on MyD88. , 2005, Journal of immunology.

[38]  H. Stockinger,et al.  M2 Polarization of Human Macrophages Favors Survival of the Intracellular Pathogen Chlamydia pneumoniae , 2015, PloS one.

[39]  Gordon Dougan,et al.  Distinctive Profiles of Infection and Pathology in Hamsters Infected with Clostridium difficile Strains 630 and B1 , 2009, Infection and Immunity.

[40]  Andrew J. Olive,et al.  Integrin α4β1 Is Necessary for CD4+ T Cell–Mediated Protection against Genital Chlamydia trachomatis Infection , 2014, The Journal of Immunology.

[41]  T. Rudel,et al.  Interaction of Chlamydiae with human macrophages , 2016, The FEBS journal.

[42]  J. Carter,et al.  The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis. , 2012, International journal of clinical rheumatology.

[43]  R. Inman,et al.  Intracellular Survival and Persistence of Chlamydia muridarum Is Determined by Macrophage Polarization , 2013, PloS one.

[44]  Amir K. Foroushani,et al.  Pathway-GPS and SIGORA: identifying relevant pathways based on the over-representation of their gene-pair signatures , 2013, PeerJ.

[45]  A. Hudson,et al.  Case Report: In Situ Hybridization for Detection of Inapparent Infection With Chlamydia trachomatis in Synovial Tissue of a Patient With Reiter's Syndrome , 1995, The American journal of the medical sciences.

[46]  J. Whittum-Hudson,et al.  In Situ Hybridization for Detection of Inapparent Infection With Chlamydia trachomatis in Synovial Tissue of a Patient With Reiter’s Syndrome , 1995 .

[47]  A. Eley,et al.  Infectivity of Chlamydia trachomatisSerovar LGV but Not E Is Dependent on Host Cell Heparan Sulfate , 2001, Infection and Immunity.

[48]  J. Fridman,et al.  Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors , 2010, Molecular Cancer Therapeutics.

[49]  Daniel J. Gaffney,et al.  Transcriptional profiling of macrophages derived from monocytes and iPS cells identifies a conserved response to LPS and novel alternative transcription , 2015, Scientific Reports.